Myriad Genetics Inc
XMUN:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XMUN:MYD
|
US |
|
S
|
Sugi Holdings Co Ltd
F:UGI
|
JP |
|
K
|
Kikkoman Corp
XMUN:KIK
|
JP |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
F
|
Farmland Partners Inc
F:0FA
|
US |
|
Clorox Co
NYSE:CLX
|
US |
|
J
|
J M Smucker Co
XMUN:JM2
|
US |
|
R
|
RPC Inc
F:RLD
|
US |
|
C
|
Campbell Soup Co
F:CSC
|
US |
|
A
|
Angi Inc
SWB:2UH
|
US |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for MYD is 3.417 EUR with a low forecast of 2.106 EUR and a high forecast of 5.254 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
3.417
EUR
According to Wall Street analysts, the average 1-year price target for MYD is 3.417 EUR with a low forecast of 2.106 EUR and a high forecast of 5.254 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
What is the Gross Profit forecast for Myriad Genetics Inc?
Projected CAGR
8%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 8%.
